The BRAF V600E-mutated tumor cell has a higher kinase activity compared with the wild type [25], which promotes proliferation and inhibits apoptosis [26], finally reducing the sensitivity to patients receiving chemotherapy drugs [22, 27]. This evidence concerns the gene BRAF and neoplasm.